BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bangolo AI, Trivedi C, Jani I, Pender S, Khalid H, Alqinai B, Intisar A, Randhawa K, Moore J, De Deugd N, Faisal S, Suresh SB, Gopani P, Nagesh VK, Proverbs-Singh T, Weissman S. Impact of gut microbiome in the development and treatment of pancreatic cancer: Newer insights. World J Gastroenterol 2023; 29(25): 3984-3998 [PMID: 37476590 DOI: 10.3748/wjg.v29.i25.3984]
URL: https://www.wjgnet.com/1007-9327/full/v29/i25/3984.htm
Number Citing Articles
1
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments at the year-end of 2023World Journal of Gastroenterology 2024; 30(1): 1-8 doi: 10.3748/wjg.v30.i1.1
2
Yu-Meng Qin, Jie Sha. Progress in understanding of relationship between intestinal microecology and pancreatic cancerWorld Chinese Journal of Digestology 2023; 31(24): 1001 doi: 10.11569/wcjd.v31.i24.1001
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
3
Adekunle Rowaiye, Gordon C. Ibeanu, Doofan Bur, Sandra Nnadi, Odinaka E. Mgbeke, Ugonna Morikwe. Gut microbiota alteration - Cancer relationships and synbiotic roles in cancer therapiesThe Microbe 2024; 4: 100096 doi: 10.1016/j.microb.2024.100096
4
Neil Daniel, Riccardo Farinella, Flavia Belluomini, Almir Fajkic, Cosmeri Rizzato, Pavel Souček, Daniele Campa, David J. Hughes. The relationship of the microbiome, associated metabolites and the gut barrier with pancreatic cancerSeminars in Cancer Biology 2025; 112: 43 doi: 10.1016/j.semcancer.2025.03.002
5
Donatella Delle Cave. Emerging Therapeutic Options in Pancreatic Cancer ManagementInternational Journal of Molecular Sciences 2024; 25(3): 1929 doi: 10.3390/ijms25031929
6
Sara Fanijavadi, Lars Henrik Jensen. Dysbiosis–NK Cell Crosstalk in Pancreatic Cancer: Toward a Unified Biomarker Signature for Improved Clinical OutcomesInternational Journal of Molecular Sciences 2025; 26(2): 730 doi: 10.3390/ijms26020730